These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 18952282)

  • 21. Re-organization of mitochondria at the NK cell immune synapse.
    Abarca-Rojano E; Muñiz-Hernández S; Moreno-Altamirano MM; Mondragón-Flores R; Enriquez-Rincón F; Sánchez-García FJ
    Immunol Lett; 2009 Jan; 122(1):18-25. PubMed ID: 19038287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early kinetics of innate and adaptive immune responses during hepatitis B virus infection.
    Fisicaro P; Valdatta C; Boni C; Massari M; Mori C; Zerbini A; Orlandini A; Sacchelli L; Missale G; Ferrari C
    Gut; 2009 Jul; 58(7):974-82. PubMed ID: 19201769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C virus (HCV): a review of immunological aspects.
    Irshad M; Khushboo I; Singh S; Singh S
    Int Rev Immunol; 2008; 27(6):497-517. PubMed ID: 19065353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunopathogenesis of psoriasis: focus on natural killer T cells.
    Peternel S; Kastelan M
    J Eur Acad Dermatol Venereol; 2009 Oct; 23(10):1123-7. PubMed ID: 19453772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural killer cells in human autoimmunity.
    Flodström-Tullberg M; Bryceson YT; Shi FD; Höglund P; Ljunggren HG
    Curr Opin Immunol; 2009 Dec; 21(6):634-40. PubMed ID: 19892538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alloreactive natural killer cells in targeting high-risk leukaemias.
    Moretta L; Locatelli F; Moretta A
    Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii39-43. PubMed ID: 19022812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities.
    Wu L; Gabriel CL; Parekh VV; Van Kaer L
    Tissue Antigens; 2009 Jun; 73(6):535-45. PubMed ID: 19392798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucocorticoid-induced tumor necrosis factor receptor-related protein ligand subverts immunosurveillance of acute myeloid leukemia in humans.
    Baessler T; Krusch M; Schmiedel BJ; Kloss M; Baltz KM; Wacker A; Schmetzer HM; Salih HR
    Cancer Res; 2009 Feb; 69(3):1037-45. PubMed ID: 19155305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IFN-alpha in the generation of dendritic cells for cancer immunotherapy.
    Santini SM; Lapenta C; Santodonato L; D'Agostino G; Belardelli F; Ferrantini M
    Handb Exp Pharmacol; 2009; (188):295-317. PubMed ID: 19031032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in activatory and inhibitory natural killer (NK) receptors may induce progression to multiple myeloma: implications for tumor evasion of T and NK cells.
    Bernal M; Garrido P; Jiménez P; Carretero R; Almagro M; López P; Navarro P; Garrido F; Ruiz-Cabello F
    Hum Immunol; 2009 Oct; 70(10):854-7. PubMed ID: 19580833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered innate immunity in chronic hepatitis C infection: cause or effect?
    Szabo G; Chang S; Dolganiuc A
    Hepatology; 2007 Oct; 46(4):1279-90. PubMed ID: 17886338
    [No Abstract]   [Full Text] [Related]  

  • 32. Dendritic cell-based cancer immunotherapies.
    Fujii S; Takayama T; Asakura M; Aki K; Fujimoto K; Shimizu K
    Arch Immunol Ther Exp (Warsz); 2009; 57(3):189-98. PubMed ID: 19479202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does our current understanding of immune tolerance, autoimmunity, and immunosuppressive mechanisms facilitate the design of efficient cancer vaccines?
    Sioud M
    Scand J Immunol; 2009 Dec; 70(6):516-25. PubMed ID: 19906192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sustained and NK/CD4+ T cell-dependent efficient prevention of lung metastasis induced by dendritic cells harboring recombinant Sendai virus.
    Komaru A; Ueda Y; Furuya A; Tanaka S; Yoshida K; Kato T; Kinoh H; Harada Y; Suzuki H; Inoue M; Hasegawa M; Ichikawa T; Yonemitsu Y
    J Immunol; 2009 Oct; 183(7):4211-9. PubMed ID: 19734206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dendritic cell-based immunotherapy in myeloid leukaemia: translating fundamental mechanisms into clinical applications.
    van de Loosdrecht AA; van den Ancker W; Houtenbos I; Ossenkoppele GJ; Westers TM
    Handb Exp Pharmacol; 2009; (188):319-48. PubMed ID: 19031033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early triggering of exclusive IFN-gamma responses of human Vgamma9Vdelta2 T cells by TLR-activated myeloid and plasmacytoid dendritic cells.
    Devilder MC; Allain S; Dousset C; Bonneville M; Scotet E
    J Immunol; 2009 Sep; 183(6):3625-33. PubMed ID: 19710464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Innate T cell responses in human gut.
    Meresse B; Cerf-Bensussan N
    Semin Immunol; 2009 Jun; 21(3):121-9. PubMed ID: 19231234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dendritic cells in viral infections.
    Belz G; Mount A; Masson F
    Handb Exp Pharmacol; 2009; (188):51-77. PubMed ID: 19031021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity.
    Kopp HG; Placke T; Salih HR
    Cancer Res; 2009 Oct; 69(19):7775-83. PubMed ID: 19738039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of bacteria as markers of leukemic lymphocytes and for the isolation of natural killer cells.
    Teodorescu M; Hsu C; Bratescu A; DeBoer KP; Nelson R; Kleinman R; Wen CM; Mayer EP; Pang EJ
    Haematol Blood Transfus; 1981; 26():355-9. PubMed ID: 7033071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.